Recurrent Treatment in Ovarian Cancer Patients: What Are the Best Regimens and the Order They Should Be Given?
Opinion Statement: The choice of the right treatment regimen for recurrent ovarian cancer (rOC) remains a case-by-case decision. It is based on multiple factors that involve patient characteristics and biological factors at the same time. The prioritization of factors is still subject to changes wit...
| Publicado en: | Current Treatment Options in Oncology Vol. 21; no. 6; pp. 1 - 14 |
|---|---|
| Autores principales: | , , , |
| Formato: | review Journal Article |
| Publicado: |
Springer Nature
Jun2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143759536&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 143759536 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15272729 3KHC jtl: Current Treatment Options in Oncology issn: 15272729 maglogo: N pubinfo: dt: Jun2020 vid: 21 iid: 6 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 143759536 143759536 NLM32350695 143759536 10.1007/s11864-020-00747-7 NLM32350695 143759536 ppf: 1 ppct: 13 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Recurrent Treatment in Ovarian Cancer Patients: What Are the Best Regimens and the Order They Should Be Given? aug: au: Glajzer, Joanna Grabowski, Jacek P. Sehouli, Jalid Pfisterer, Jacobus affil: Department of Gynecology and Center of Oncological Surgery, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany sug: subj: Ovarian Neoplasms Therapy Disease Management Algorithms Treatment Outcomes Repeat Procedures Female Recurrence Ovarian Neoplasms Pathology Combined Modality Therapy Methods Scales Female ab: Opinion Statement: The choice of the right treatment regimen for recurrent ovarian cancer (rOC) remains a case-by-case decision. It is based on multiple factors that involve patient characteristics and biological factors at the same time. The prioritization of factors is still subject to changes with a trend towards a more personalized medicine. Therefore, participation and engagement in clinical studies constitutes a substantial need for the future development of the treatment algorithm of rOC. pubtype: Academic Journal doctype: review Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|